The UK NSC recommendation on Blood group & RhD status and red cell alloantibodies screening in pregnancy (currently under review)
Find general information about population health screening.
More about Blood group & RhD status and red cell alloantibodies
Identifying blood group, rhesus D status and red cell antibodies in pregnant women is important to prevent haemolytic disease of the newborn and to identify possible transfusion problems. Haemolytic disease of the newborn, or rhesus disease, happens when antibodies in a mother's blood attack her baby's blood cells. It may cause jaundice, severe anaemia, heart failure and death.
The stakeholder groups will be involved when the recommendation is next reviewed. If you think your organisation should be added, please contact us. More information for stakeholders can be found in appendix C of the UK NSC evidence review process.
More optionsGo to top